Filing Flows

Filing Flows › Companies › Femasys › Cash flow

Femasys cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$3.9M in Q2 2026 · −$18.1M over twelve months

Operating cash flow−$3.9M
Capital spending−$9K
Free cash flow−$3.9M
Cash conversion cycle2715 days

Analysis

In Q2 2026, Femasys generated −$3.9M of operating cash flow and spent $9K on capital projects, leaving free cash flow of −$3.9M. That is $502K more than in Q2 2025 (−$4.4M).

Over the twelve months to Jun 30, 2026, operating cash flow was −$17.7M; the largest uses were operating cash flow ($17.7M), capital spending ($423K), other investing ($115K); besides operations, cash came from other financing ($16.4M), shares issued ($65K); the cash balance fell by $1.8M.

Operating cash flow was −$3.9M against net income of −$4.5M. The largest differences: payables +$753K, stock-based pay +$211K, prepaid and other assets +$140K.

Its cash conversion cycle was 2715 days (receivables 44 + inventory 3928 − payables 1257).

Free cash flow

Femasys: free cash flow by quarterFemasys: free cash flow by quarter−$5.9MQ3 2024−$5.2MQ4 2024−$4.9MQ1 2025−$4.4MQ2 2025−$5.6MQ3 2025−$4.3MQ4 2025−$4.2MQ1 2026−$3.9MQ2 2026
Operating cash flow less capital spending.
Femasys: operating cash flow against capital spendingFemasys: operating cash flow against capital spendingOperating cash flowCapital spending−$5.5M$408KQ3 2024−$5.1M$107KQ4 2024−$4.8M$97KQ1 2025−$4.4M$94KQ2 2025−$5.4M$194KQ3 2025−$4.2M$140KQ4 2025−$4.1M$79KQ1 2026−$3.9M$9KQ2 2026
Latest (Q2 2026): Operating cash flow −$3.9M, Capital spending $9K.

Capital allocation, year by year

Femasys: where the cash came from (up) and went (down), by fiscal yearFemasys: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingBuybacksFY2021: Operating cash flow −$7.9MFY2021: Net borrowing −$463KFY2021: Shares issued $31.7MFY2021: Capital spending −$307K$31.7MFY2021FY2022: Operating cash flow −$10.7MFY2022: Net borrowing −$23KFY2022: Shares issued $99KFY2022: Capital spending −$407K$99KFY2022FY2023: Operating cash flow −$11.3MFY2023: Net borrowing $6.3MFY2023: Shares issued $7.7MFY2023: Capital spending −$144KFY2023: Buybacks −$230K$14.0MFY2023FY2024: Operating cash flow −$19.4MFY2024: Shares issued $2.1MFY2024: Capital spending −$762KFY2024: Buybacks −$61K$2.1MFY2024FY2025: Operating cash flow −$18.7MFY2025: Net borrowing $5.2MFY2025: Shares issued $90KFY2025: Capital spending −$525K$5.3MFY2025
Over these 5 years operating cash flow totalled −$68.1M; the largest uses were operating cash flow ($68.1M) and capital spending ($2.1M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$1.4M
Debtnone
Net cash$1.4M
Cash runway1 month

Femasys is burning cash: its operations consume cash, a free cash flow of −$18.1M a year at the current rate against $1.4M of cash and investments: a runway of about 1 month before any new financing.

Where the cash came from and went

Femasys: sources (+) and uses (−) of cash, Q2 2026Femasys: sources (+) and uses (−) of cash, Q2 2026Cash drawn (+) / kept (−)$3.9MOperating cash flow−$3.9MOther financing$15KOther investing−$13KCapital spending−$9K
Femasys: sources (+) and uses (−) of cash, TTM to Q2 2026Femasys: sources (+) and uses (−) of cash, TTM to Q2 2026Operating cash flow−$17.7MOther financing$16.4MCash drawn (+) / kept (−)$1.8MCapital spending−$423KOther investing−$115KShares issued$65K

From profit to cash

Femasys: net income to operating cash flow, Q2 2026Femasys: net income to operating cash flow, Q2 2026Net income−$4.5MDepreciation & amortization$83KStock-based pay$211KReceivables$21KInventory−$86KPayables$753KAccrued liabilities$9KPrepaid and other assets$140KOther liabilities−$10KOperating cash flow−$3.9M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 202644392812572715
Q1 20268433619732472
Q4 20256717496081208
Q3 2025521725851926
Q2 202554261616101061
Q1 202595265114391307
Q4 2024691192607653
Q3 202439784500323

Every quarter

QuarterOperating cash flowCapital spendingBuybacksNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$3.9M−$9K———$3.9M−$3.9M
Q1 2026−$4.1M−$79K———$3.9M−$4.2M
Q4 2025−$4.2M−$140K—−$276K$49K−$4.7M−$4.3M
Q3 2025−$5.4M−$194K———−$1.4M−$5.6M
Q2 2025−$4.4M−$94K——−$882K$602K−$4.4M
Q1 2025−$4.8M−$97K−$162K—$5.4M−$368K−$4.9M
Q4 2024−$5.1M−$107K−$30K—$1.1M$4.2M−$5.2M
Q3 2024−$5.5M−$408K——$1.0M$5.9M−$5.9M

Femasys: income statement and cash flow

Femasys, Q2 2026: revenue $332K (-19% year over year). The chart follows the revenue to costs, profit and cash.

Femasys: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.